NUVL NUVALENT INC-A
2026Q1 · CUSIP 670703107 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
263
Δ holders QoQ
+26
Breadth percentile
Top 12%
Whale holders
140
Δ whales
+17
Inst. holding value
$8.0B
New positions
57
Closed positions
31
Price momentum (1Q)
-2.3%
Put / Call
3/3
Breadth history (34 quarters)
Past Lit Events & Aftermath 7 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 12% | — | — |
| 2025Q4 | Top 14% | -2.3% | — |
| 2024Q3 | Top 16% | -9.4% | -16.5% |
| 2024Q1 | Top 12% | +5.6% | +22.6% |
| 2023Q4 | Top 13% | -17.8% | -13.1% |
| 2023Q2 | Top 10% | +40.3% | +101.6% |
| 2022Q4 | Top 10% | +26.5% | +34.2% |
Options Sentiment
Put holders
3
QoQ: +2
Call holders
3
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-6.06
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)